📖

Atypical Parkinsonism

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-diseases-atypical-parkinsonism
Related Entities
diseases-atypical-parkinsonism
Metadata
slugdiseases-atypical-parkinsonism
entity_typedisease
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (103)
mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna60%
mentions🧪Vocal Cord Neuroplasticity Stimulation60%
mentions🧪Vagal Afferent Microbial Signal Modulation60%
mentions🧪Microbial Inflammasome Priming Prevention60%
mentions🧫Combination Therapy Sequencing in Parkinson's Disease60%
mentions🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#60%
mentions🧫Parkinson's Disease Subtype Classification — Precision 60%
mentions🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D60%
related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna54%
related🧪Vocal Cord Neuroplasticity Stimulation54%
related🧪Vagal Afferent Microbial Signal Modulation54%
related🧪Microbial Inflammasome Priming Prevention54%
related🧫Combination Therapy Sequencing in Parkinson's Disease54%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#54%
related🧫Parkinson's Disease Subtype Classification — Precision 54%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D54%
mentions🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio50%
mentions🧫tACS Connectivity Trial in Early Alzheimer's50%
mentions🧫Microbiome-Gut Barrier Signatures in ALS — Experiment Design50%
mentions🧫iPSC-NPC effects on astrocytes in vitro ICH model50%
mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring50%
mentions🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne50%
mentions🧫RBG treatment in ApoE-/- atherosclerosis mouse model50%
mentions🧫Leukocyte gene expression analysis in COVID-19 patients50%
mentions🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise50%
mentions🧪Enteric Nervous System Prion-Like Propagation Blockade50%
mentions🧪Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam50%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%
mentions🧪APOE Isoform Conversion Therapy50%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%
mentions🧪Competitive APOE4 Domain Stabilization Peptides50%
mentions🧪APOE Isoform Expression Across Glial Subtypes50%
mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying protein aggregation cross50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬How does metabolic reprogramming (glucose metabolism shifts,50%
related🧪Biorhythmic Interference via Controlled Sleep Oscillations50%
related🧪Mitochondrial-Lysosomal Contact Site Engineering50%
related🧪Lysosomal Membrane Repair Enhancement50%
related🧪Lysosomal Calcium Channel Modulation Therapy50%
related🧪Lysosomal Enzyme Trafficking Correction50%
related🧪Serine/Arginine-Rich Protein Kinase Modulation50%
related🧪Complement C1QA Spatial Gradient in Cortical Layers50%
related🧪Lysosomal Positioning Dynamics Modulation50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
mentions🧫CRISPR Gene Correction Approaches for CBS/PSP44%
mentions🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation44%
mentions🧫TLR expression in α-synuclein overexpressing mice44%
mentions🧫TLR expression analysis in Parkinson's disease patients44%
mentions🧫TLR4 Activation Assay with NETs and Anti-CarP Antibodies44%
mentions📖Adam L. Boxer40%
mentions📖Angelo Antonini, MD, PhD — Movement Disorder Specialist40%
mentions📖Boston Scientific40%
mentions📖Brian Roels — PSP Neuropathology Researcher40%
mentions📖Carlo Ferraro — Movement Disorder Researcher40%
mentions📖Cedars-Sinai Medical Center40%
mentions📖Cegedim40%
mentions📖Chiara Marsili — PSP Researcher40%
mentions📖ClearSky Medical Diagnostics40%
mentions📖Dalhousie University40%
mentions📖David Irwin40%
mentions📖Günter Höglinger40%
mentions📖Hirofumi Yoshino — Tauopathy Researcher40%
mentions📖Huw Morris40%
mentions📖James Leverenz40%
mentions📖KU Leuven40%
mentions📖Kailash Bhatia40%
mentions📖Lauren Shore40%
mentions📖Lundbeck40%
mentions📖Marc H. Smith40%
mentions📖Maria Bernardino — PSP Researcher40%
mentions📖Masahiro Kato — PSP Researcher40%
mentions📖Mayo Clinic Jacksonville40%
mentions📖Mount Sinai Hospital40%
mentions📖Movement Disorder Specialists Directory40%
mentions📖Nicola Ray — Movement Disorder Researcher40%
mentions📖Nicolas Lambrecq40%
mentions📖Patricia Martinez — PSP Clinical Trials Researcher40%
mentions📖RightEye40%
mentions📖Rohit Das — Movement Disorder Specialist40%
mentions📖Tetsuya Kimura40%
mentions📖University of British Columbia40%
mentions📖University of Cincinnati40%
mentions📖University of Heidelberg40%
mentions📖University of Sao Paulo40%
mentions📖University of Southern California40%
mentions📖Werner Poewe — International Movement Disorder Expert40%
mentions📖Zbigniew Wszolek40%
mentions📖movo40%
mentions📖uthealth-houston40%
mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa40%
mentions🔬What are the mechanisms underlying protein aggregation cross40%
mentions🔬How does metabolic reprogramming (glucose metabolism shifts,40%
related🧪Enteric Nervous System Prion-Like Propagation Blockade40%

💬 Discussion